Blog
About

7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A comparison of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease: a meta-analysis.

      Human Psychopharmacology

      Treatment Outcome, therapeutic use, Piperidines, Nootropic Agents, Male, Indans, Humans, Galantamine, psychology, etiology, drug therapy, Cognition Disorders, Cholinesterase Inhibitors, Alzheimer Disease, Aged

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This review was conducted in order to determine the efficacy of donepezil and galantamine in the treatment of cognitive symptoms of Alzheimer's disease, and also to determine whether galantamine was a superior pharmacological intervention. Meta-analytic methods were used to analyse the data from eight empirical studies which met the inclusion criteria specified. By finding the mean effect sizes of the treatment on the outcome measures of cognition, it was determined that neither drug was greatly efficacious. However, this result does not necessarily diminish the practical value of the drug. It was also found that galantamine was no better than donepezil at treating cognitive decline in AD. Copyright (c) 2005 John Wiley & Sons, Ltd.

          Related collections

          Author and article information

          Journal
          15700322
          10.1002/hup.676

          Comments

          Comment on this article